Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene
- PMID: 3299059
- PMCID: PMC365313
- DOI: 10.1128/mcb.7.5.2019-2023.1987
Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene
Abstract
We investigated alterations in the structure and expression of oncogenes in mammary tumors and mammary tumor-derived cell lines. In 16 of 95 samples, we detected amplification of the human neu oncogene, also known as c-erB-2, accompanied by overexpression in the tumors from which intact RNA could be isolated. In 10 of these DNAs, the linked oncogene c-erbA was also amplified, whereas another gene on human chromosome 17, p53, was present in normal copy numbers. Overexpression of c-erbA could not be detected in the tumors analyzed. The relatively high frequency of neu amplification points to a functional role in human breast cancer. Coamplification of the c-erbA oncogene could contribute to this disease as well but is most likely fortuitous.
Similar articles
-
Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.Oncogene. 1988 Mar;2(3):283-7. Oncogene. 1988. PMID: 3281095
-
c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.Br J Cancer. 1989 Oct;60(4):505-10. doi: 10.1038/bjc.1989.303. Br J Cancer. 1989. PMID: 2572268 Free PMC article.
-
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.Cancer Res. 1991 Jan 15;51(2):556-67. Cancer Res. 1991. PMID: 1670762
-
The neu (c-erbB-2) oncogene.Semin Oncol. 1989 Apr;16(2):148-55. Semin Oncol. 1989. PMID: 2565604 Review.
-
The significance of oncogene amplification in primary breast cancer.Int J Cancer. 1989 Feb 15;43(2):270-2. doi: 10.1002/ijc.2910430218. Int J Cancer. 1989. PMID: 2563720 Review.
Cited by
-
p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.Mol Cell Biol. 1989 Mar;9(3):1165-72. doi: 10.1128/mcb.9.3.1165-1172.1989. Mol Cell Biol. 1989. PMID: 2566907 Free PMC article.
-
Association of elevated expression of the c-erbB-2 protein with spread of breast cancer.Jpn J Cancer Res. 1989 Dec;80(12):1192-8. doi: 10.1111/j.1349-7006.1989.tb01654.x. Jpn J Cancer Res. 1989. PMID: 2576425 Free PMC article.
-
Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659).EMBO J. 1990 Jan;9(1):181-90. doi: 10.1002/j.1460-2075.1990.tb08094.x. EMBO J. 1990. PMID: 2153076 Free PMC article.
-
c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.J Clin Pathol. 1992 Jan;45(1):16-20. doi: 10.1136/jcp.45.1.16. J Clin Pathol. 1992. PMID: 1346789 Free PMC article.
-
Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.Am J Pathol. 2000 Mar;156(3):839-47. doi: 10.1016/s0002-9440(10)64952-8. Am J Pathol. 2000. PMID: 10702400 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous